X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-09-08 | CCEL | Cryo Cell International Inc | Portnoy David | COB, Co-CEO, 10% | P - Purchase | $4.43 | +42,900 | 1,479,655 | +3% | +$189,986 | |||||
2025-09-05 | SHC | Sotera Health Co | Warburg Pincus & Co. | Dir, 10% | S - Sale | $15.11 | -12,000,000 | 61,822,952 | -16% | -$181,332,000 | ||||||
2025-09-05 | SHC | Sotera Health Co | Warburg Pincus & Co. | Dir, 10% | S - Sale | $15.11 | -12,000,000 | 61,822,952 | -16% | -$181,332,000 | ||||||
2025-09-05 | SHC | Sotera Health Co | Gtcr Investment Xi LLC | Dir, 10% | S - Sale | $15.11 | -8,000,000 | 41,215,301 | -16% | -$120,888,000 | ||||||
2025-09-04 | PGNY | Progyny, Inc. | Swartz Allison | EVP, GC | S - Sale | $23.53 | -599 | 77,407 | -1% | -$14,094 | ||||||
2025-08-28 | PGNY | Progyny, Inc. | Swartz Allison | EVP, GC | S - Sale | $22.96 | -2,398 | 78,345 | -3% | -$55,058 | ||||||
| DM | 2025-08-25 | CCEL | Cryo Cell International Inc | Portnoy David | COB, Co-CEO, 10% | P - Purchase | $4.50 | +39,179 | 1,635,383 | +2% | +$176,198 | |||||
| D | 2025-08-22 | SHC | Sotera Health Co | Rutz Michael P | Pres of Sterigenics | S - Sale+OE | $16.38 | -126,611 | 450,204 | -22% | -$2,074,306 | |||||
| DM | 2025-08-15 | CCEL | Cryo Cell International Inc | Portnoy David | COB, Co-CEO, 10% | P - Purchase | $4.41 | +19,301 | 1,596,204 | +1% | +$85,078 | |||||
| D | 2025-08-14 | CCEL | Cryo Cell International Inc | Portnoy David | COB, Co-CEO, 10% | P - Purchase | $4.17 | +5,826 | 1,576,903 | 0% | +$24,305 | |||||
2025-08-13 | VMD | Viemed Healthcare, Inc. | Cambre Jerome | VP of Sales | S - Sale | $7.32 | -4,880 | 84,191 | -5% | -$35,737 | ||||||
2025-08-11 | PGNY | Progyny, Inc. | Gordon Kevin K | Dir | S - Sale | $22.04 | -2,500 | 20,527 | -11% | -$55,088 | ||||||
2025-08-12 | VMD | Viemed Healthcare, Inc. | Moore Michael | Pres | S - Sale | $7.33 | -50,090 | 1,848,957 | -3% | -$367,160 | ||||||
2025-07-29 | MRAI | Marpai, Inc. | Lamendola Damien | CEO, 10% | P - Purchase | $1.08 | +371,470 | 7,107,606 | +6% | +$399,999 | ||||||
2025-07-23 | DVA | Davita Inc. | Hearty James O | Chief Compliance Officer | S - Sale | $150.00 | -2,351 | 26,038 | -8% | -$352,650 | ||||||
2025-07-17 | MRAI | Marpai, Inc. | Lamendola Damien | CEO, 10% | P - Purchase | $1.15 | +86,805 | 6,736,136 | +1% | +$99,999 | ||||||
2025-07-17 | OAKU | Oak Woods Acquisition Corp | Mizuho Securities USA LLC | 10% | S - Sale | $11.91 | -61,100 | 352,816 | -15% | -$727,701 | ||||||
| DM | 2025-06-27 | VMD | Viemed Healthcare, Inc. | Moore Michael | Pres | S - Sale+OE | $6.92 | -181,316 | 1,900,047 | -9% | -$1,255,493 | |||||
| D | 2025-06-30 | VMD | Viemed Healthcare, Inc. | Kaushal Nitin | Dir | S - Sale+OE | $6.91 | -7,048 | 126,843 | -5% | -$48,702 | |||||
| DM | 2025-06-26 | VMD | Viemed Healthcare, Inc. | Kaushal Nitin | Dir | S - Sale+OE | $7.01 | -42,952 | 126,843 | -25% | -$301,005 | |||||
2025-06-11 | PGNY | Progyny, Inc. | Scott Cheryl | Dir | S - Sale | $22.07 | -2,675 | 14,112 | -16% | -$59,037 | ||||||
| AD | 2023-11-29 | AGL | Agilon Health, Inc. | Schwaneke Jeffrey A. | CFO | P - Purchase | $11.22 | +22,300 | 1,152,852 | +2% | +$250,206 | |||||
2025-03-14 | AGL | Agilon Health, Inc. | Sell Steven | CEO, Pres | P - Purchase | $0.00 | +42,426 | 422,900 | +11% | +$0 | ||||||
2025-03-14 | AGL | Agilon Health, Inc. | Shaker Benjamin | Chief Markets Officer | P - Purchase | $0.00 | +11,786 | 457,058 | +3% | +$0 | ||||||
2025-03-14 | AGL | Agilon Health, Inc. | Venkatachaliah Girish | CTO | P - Purchase | $0.00 | +9,429 | 155,120 | +6% | +$0 | ||||||
| M | 2025-03-13 | VMD | Viemed Healthcare, Inc. | Smokoff Timothy | Dir | S - Sale | $7.70 | -11,865 | 79,786 | -13% | -$91,364 | |||||
2024-12-26 | QIPT | Quipt Home Medical Corp. | Gamble Patrick Dennis | EVP Operations | P - Purchase | $2.45 | +17,000 | 40,057 | +74% | +$41,634 | ||||||
2024-12-26 | PGNY | Progyny, Inc. | Schlanger David J | Exec COB | P - Purchase | $14.68 | +150,000 | 228,269 | +192% | +$2,202,330 | ||||||
2024-12-23 | PGNY | Progyny, Inc. | Anevski Peter | CEO | P - Purchase | $14.48 | +209,500 | 441,464 | +90% | +$3,034,084 | ||||||
2024-12-13 | AGL | Agilon Health, Inc. | McLoughlin Karen | Dir | P - Purchase | $2.20 | +25,000 | 73,166 | +52% | +$55,085 | ||||||
2024-12-11 | AGL | Agilon Health, Inc. | Battaglia Silvana | Dir | P - Purchase | $2.01 | +25,062 | 66,144 | +61% | +$50,269 | ||||||
| M | 2024-11-25 | AGL | Agilon Health, Inc. | McKenzie Diana | Dir | P - Purchase | $2.25 | +20,000 | 58,819 | +52% | +$44,963 | |||||
2024-12-05 | AGL | Agilon Health, Inc. | Wulf John William | Dir | P - Purchase | $2.18 | +45,000 | 206,133 | +28% | +$98,145 | ||||||
2024-12-05 | MRAI | Marpai, Inc. | Powers John Paul | Pres, COO | P - Purchase | $1.13 | +10,000 | 260,000 | +4% | +$11,300 | ||||||
2024-12-05 | MRAI | Marpai, Inc. | Johnson Steve Andrew | CFO | P - Purchase | $1.13 | +5,000 | 473,061 | +1% | +$5,650 | ||||||
2024-12-05 | MRAI | Marpai, Inc. | Eitan Yaron | Dir | P - Purchase | $1.13 | +110,619 | 789,073 | +16% | +$124,999 | ||||||
| DM | 2024-11-25 | VMD | Viemed Healthcare, Inc. | Kaushal Nitin | Dir | S - Sale+OE | $8.68 | -30,000 | 126,843 | -19% | -$260,281 | |||||
2024-11-20 | OTRK | Ontrak, Inc. | Sherman Michael Edward | Dir | S - Sale | $1.77 | -173 | 0 | -100% | -$306 | ||||||
| DM | 2024-11-19 | VMD | Viemed Healthcare, Inc. | Kaushal Nitin | Dir | S - Sale+OE | $8.53 | -30,000 | 126,843 | -19% | -$255,900 | |||||
| D | 2024-11-13 | VMD | Viemed Healthcare, Inc. | Dobbs Randy E. | Dir | S - Sale+OE | $9.28 | -36,261 | 107,706 | -25% | -$336,502 | |||||
| DM | 2024-11-11 | VMD | Viemed Healthcare, Inc. | Kaushal Nitin | Dir | S - Sale+OE | $9.52 | -60,000 | 126,843 | -32% | -$571,200 | |||||
2024-10-28 | BRTX | Biorestorative Therapies, Inc. | Broadrick Dale | 10% | S - Sale | $1.58 | -1,112 | 923,905 | 0% | -$1,757 | ||||||
2024-10-09 | OAKU | Oak Woods Acquisition Corp | Mizuho Securities USA LLC | 10% | S - Sale | $11.18 | -74,000 | 413,394 | -15% | -$827,320 | ||||||
| M | 2024-09-13 | DVA | Davita Inc. | Rodriguez Javier | CEO | S - Sale | $164.69 | -59,881 | 837,835 | -7% | -$9,861,637 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |